Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Repurposing Drugs in Oncology (ReDO)—Propranolol as an anti-cancer agent
Pan Pantziarka, Gauthier Bouche, Vidula Sukhatme, et al.
ecancermedicalscience (2016) Vol. 10
Open Access | Times Cited: 104

Showing 1-25 of 104 citing articles:

Preoperative β-Blockade with Propranolol Reduces Biomarkers of Metastasis in Breast Cancer: A Phase II Randomized Trial
Jonathan G. Hiller, Steve W. Cole, Elizabeth M. Crone, et al.
Clinical Cancer Research (2019) Vol. 26, Iss. 8, pp. 1803-1811
Open Access | Times Cited: 148
Drug repurposing: Misconceptions, challenges, and opportunities for academic researchers
C. Glenn Begley, Mark Ashton, Jonathan B. Baell, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 612
Closed Access | Times Cited: 113
Blockade of beta-adrenergic receptors reduces cancer growth and enhances the response to anti-CTLA4 therapy by modulating the tumor microenvironment
Klaire Yixin Fjæstad, Anne Mette Askehøj Rømer, Victor Goitea, et al.
Oncogene (2022) Vol. 41, Iss. 9, pp. 1364-1375
Open Access | Times Cited: 73
Repurposing of drugs: An attractive pharmacological strategy for cancer therapeutics
Anuradha Kirtonia, Kavita Gala, Stina George Fernandes, et al.
Seminars in Cancer Biology (2020) Vol. 68, pp. 258-278
Closed Access | Times Cited: 135
Adrenergic Signaling: A Targetable Checkpoint Limiting Development of the Antitumor Immune Response
Guanxi Qiao, Minhui Chen, Mark J. Bucsek, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 131
Anti-proliferation of breast cancer cells with itraconazole: Hedgehog pathway inhibition induces apoptosis and autophagic cell death
Xiaoya Wang, Sanhua Wei, Yong Zhao, et al.
Cancer Letters (2016) Vol. 385, pp. 128-136
Closed Access | Times Cited: 100
Propranolol sensitizes prostate cancer cells to glucose metabolism inhibition and prevents cancer progression
Laura Brohée, Olivier Peulen, Betty Nusgens, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 70
Propranolol suppresses the proliferation and induces the apoptosis of liver cancer cells
Fang Wang, Hui Liu, Fengmei Wang, et al.
Molecular Medicine Reports (2018)
Open Access | Times Cited: 66
Repurposing drugs in oncology: From candidate selection to clinical adoption
Pan Pantziarka, Ciska Verbaanderd, Isabelle Huys, et al.
Seminars in Cancer Biology (2020) Vol. 68, pp. 186-191
Open Access | Times Cited: 54
Carvedilol blocks neural regulation of breast cancer progression in vivo and is associated with reduced breast cancer mortality in patients
Ryan D. Gillis, Edoardo Botteri, Aeson Chang, et al.
European Journal of Cancer (2021) Vol. 147, pp. 106-116
Open Access | Times Cited: 51
Molecular docking and dynamics simulations reveal the potential of anti-HCV drugs to inhibit COVID-19 main protease
Ahmed A. Al‐Karmalawy, Radwan Alnajjar, Mohammed A. Dahab, et al.
Pharmaceutical Sciences (2021)
Open Access | Times Cited: 49
New Approaches in Oncology for Repositioning Drugs: The Case of PDE5 Inhibitor Sildenafil
Marian Cruz-Burgos, Alberto Losada-García, Carlos D. Cruz-Hernández, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 45
Chronic restraint stress promotes the mobilization and recruitment of myeloid‐derived suppressor cells through β‐adrenergic‐activated CXCL5‐CXCR2‐Erk signaling cascades
Mingyue Cao, Wei Huang, Yuzhu Chen, et al.
International Journal of Cancer (2021) Vol. 149, Iss. 2, pp. 460-472
Open Access | Times Cited: 43
Muscle wasting: emerging pathways and potential drug targets
Aylin Domaniku, Şevval Nur Bilgiç, Serkan Kır
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 10, pp. 705-718
Closed Access | Times Cited: 18
Social Genomic Determinants of Health: Understanding the Molecular Pathways by Which Neighborhood Disadvantage Affects Cancer Outcomes
Neha Goel, Alexandra Hernández, Steve W. Cole
Journal of Clinical Oncology (2024) Vol. 42, Iss. 30, pp. 3618-3627
Closed Access | Times Cited: 7
Clinical, Diagnostic, and Treatment Characteristics of SDHA-Related Metastatic Pheochromocytoma and Paraganglioma
Abhishek Jha, Kristine de Luna, Charlene Ann Balili, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 54
Repurposing drugs in oncology (ReDO)—selective PDE5 inhibitors as
Pan Pantziarka, Vidula Sukhatme, Sergio Crispino, et al.
ecancermedicalscience (2018) Vol. 12
Open Access | Times Cited: 48
Therapeutic Targeting of Cancer Stem Cells via Modulation of the Renin-Angiotensin System
Imogen Roth, Agadha Wickremesekera, Susrutha K. Wickremesekera, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 43
A novel drug repurposing approach for non-small cell lung cancer using deep learning
Bingrui Li, Chan Dai, Lijun Wang, et al.
PLoS ONE (2020) Vol. 15, Iss. 6, pp. e0233112-e0233112
Open Access | Times Cited: 42
Propranolol Reduces the Development of Lesions and Rescues Barrier Function in Cerebral Cavernous Malformations
Joppe Oldenburg, Matteo Malinverno, Maria Ascención Globisch, et al.
Stroke (2021) Vol. 52, Iss. 4, pp. 1418-1427
Open Access | Times Cited: 41
Repurposing of Chronically Used Drugs in Cancer Therapy: A Chance to Grasp
Mohamad Ali Hijazi, André Gessner, Nahed El‐Najjar
Cancers (2023) Vol. 15, Iss. 12, pp. 3199-3199
Open Access | Times Cited: 16
Dichloroacetate for Cancer Treatment: Some Facts and Many Doubts
Tomas Koltai, Larry Fliegel
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 744-744
Open Access | Times Cited: 5
Non-selective beta blockers inhibit angiosarcoma cell viability and increase progression free- and overall-survival in patients diagnosed with metastatic angiosarcoma
Clarissa Amaya, Mariah Perkins, Andres Belmont, et al.
Oncoscience (2018) Vol. 5, Iss. 3-4, pp. 109-119
Open Access | Times Cited: 45
New uses for old drugs
Pan Pantziarka, Munir Pirmohamed, Nasir Mirza
BMJ (2018), pp. k2701-k2701
Closed Access | Times Cited: 40
Critical role of Aquaporin-1 and telocytes in infantile hemangioma response to propranolol beta blockade
François Moisan, Sandra Ouchérif, Priscilla Kaulanjan‐Checkmodine, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 7
Open Access | Times Cited: 32
Page 1 - Next Page

Scroll to top